AK
Alam Kamran
Chief Financial Officer
OtherM
Insider track record
CFONot enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Alam Kamran, Chief Financial Officer. Director active across 2 companies, notably Taysha Gene Therapies, Inc.. Aggregated, 15 filings have been recorded. Breakdown: 0 buy · 8 sells. Total volume traded: €829k. History available since 18 August 2021. The latest transaction was filed on 4 February 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Alam Kamran
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations15 total
1,655 shares@ US$4.524.5% of flowCommon StockSEC:0001793412-26-000012:0
78,968 shares@ US$4.7535.3% of flowCommon StockSEC:0001793412-26-000008:0
23,849 shares@ US$4.6110.3% of flowCommon StockSEC:0001793412-26-000008:1
359,000 shares0Common StockSEC:0001793412-26-000002:0
54,491 shares@ US$2.85100.0% of flowCommon StockSEC:0001415889-25-022749:0
29,843 shares@ US$1.695.2% of flowCommon StockSEC:0001415889-25-007997:0
431,000 shares0Common StockSEC:0001415889-25-000595:0
1,288 shares@ US$1.510.2% of flowCommon StockSEC:0001415889-24-002809:0
590,413 shares0Common StockSEC:0001209191-24-000811:0
33,000 shares@ US$2.337.9% of flowCommon StockSEC:0001209191-23-047323:0
6,230 sharesCommon StockSEC:0001209191-23-033681:0
18,691 sharesCommon StockSEC:0001209191-23-007396:0
3,325 shares@ US$3.471.3% of flowCommon StockSEC:0001209191-22-047353:0
7,476 shares@ US$3.873.2% of flowCommon StockSEC:0001209191-22-047097:0
11,193 shares@ US$17.3522.5% of flowCommon StockSEC:0001209191-21-052824:0
About Alam Kamran
Alam Kamran is Chief Financial Officer at Taysha Gene Therapies, Inc. He has 15 filings in total, and in the recent sample of 15 filings, the transactions are sales, totaling EUR 829265 between 2021-08-20 and 2026-02-06.